메디포스트 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 마블2022홀딩스, was filed 20 Jan 2026.
메디포스트: what insiders have been doing
Every trade that managers of 메디포스트 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. 5 insiders have disclosed 5 filings since 1 November 2025.
The record shows 3 purchases on the open market, made by 3 insiders, against 1 sale by 1 insider. The totals exclude 4 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Compared with its exchange (2,655 companies, median 7 filings), a count of 5 filings is below the norm. Looking back to 2021, when coverage begins, insiders filed 15 purchases and 42 sales.
The clock since the last published purchase (20 January 2026) now reads 294 days. Typically, a trade is published a median of 7 days after it takes place. This delay matters because a trade only becomes useful information once it is public.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -31.8%Entry ₩12,703 · Close at T+365 ₩8,660
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- ●Executives0DART
- 21,290,073 sharesKRXDART:20260120000182Canonical exit: 13 Apr 2026 (T+90)
- 24,070,786 sharesKRXDART:20260113000733Canonical exit: 6 Apr 2026 (T+90)
- 18,509,361 sharesKRXDART:20260113000742
- 3,058,783 sharesKRXDART:20260107000318Canonical exit: 30 Mar 2026 (T+90)
- 703,717 sharesKRXDART:20251002000398Canonical exit: 7 Feb 2024 (T+90)
- 18,509,627 sharesKRXDART:20251002000403
- 121 sharesShareKRXDART:20250930000363
- 133 sharesShareKRXDART:20250930000573
- 18,830,908 sharesKRXDART:20250930000395
- ●Executives0DART
- ●Executives0DART
- 703,717 sharesKRXDART:20231116000484Canonical exit: 7 Feb 2024 (T+90)
- ShareKRXDART:20231116000500
- ShareKRXDART:20231116000505
- ShareKRXDART:20231116000495
- ShareKRXDART:20231116000491
- ShareKRXDART:20231115000156
- ShareKRXDART:20231115000161
- ShareKRXDART:20231030000339
- ShareKRXDART:20231030000348
- ShareKRXDART:20231030000321
- ShareKRXDART:20231027000287
- ShareKRXDART:20231027000306
25 of 68 declarations
About 메디포스트
메디포스트 is a company in the health and pharmaceutical sector, listed on the XKRX. It focuses on the development of cell therapies and biopharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations